Want to join the conversation?
$JNJ 2Q15 Q&A Update-Sandra: In insulin delivery, we effectively launched in US at beginning of this year & seen significant positive growth & uptick of product, which is combination of existing patients upgrading to new product, as well as gaining new to therapy insulin pumpers & seen lot of conversion from other pump platforms to our platform.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.